Health Care

In many ways, U.S. health care is the envy of the world—it has helped many individuals live longer than ever and enjoy a better quality of life than previously possible. However, we continue to face the challenge of making quality health care more affordable, more accessible, and more reliable for all Americans. 

The Chamber is focused on promoting effective private sector solutions to our health care challenges that will help control costs, expand access, and improve the quality of care.

Projects and Programs

 

 


Our Priorities

Our goal is to Expand access to and improve the affordability of high-quality health care services for all Americans. 

Priorities

Access and Affordability
  • Enable greater flexibility for businesses as they offer health care coverage to their employees. 
  • Support the expansion of Association Health Plans. 
  • Adopt policies to stabilize the individual and small group markets. 
  • Improve access to meaningful cost and quality information for consumers while protecting the ability of private companies to enter into negotiated contractual arrangements. 
  • Facilitate the adoption of value-based insurance and reward high-quality providers.
Wellness, Innovation, and Value 
  • Facilitate and promote workplace wellness programs. 
  • Protect consumer safety by stopping unregulated foreign drug imports and curbing the opioid epidemic. 
  • Oppose price controls and efforts that reduce contractual flexibility in our health care system. 
  • Oppose the adoption of a single-payer, government-run health care system. 
  • Support reforms that lead to more value-based, quality-focused, and coordinated care. 

     

Our Successes

Recent Successes

Repeal the Cadillac Tax

This 40% excise tax on employer-sponsored health coverage threatened the value of health benefits for over 180 million Americans. Repeal is projected to save $197 billion over a 10-year period.

Repeal the Health Insurance Tax

The tax on health insurance raised premiums for small businesses, seniors, and millions of others. Repeal is projected to save $150.8 billion over the next decade.

Repeal the Medical Device Tax

The 2.3% tax on the sale of medical devices hurt the ability of American companies to compete and encouraged businesses to send operations and jobs overseas. Repeal is projected to save $25.5 billion over the next decade.

Improve Treatment of Chronic Conditions

IRS guidance delineated 14 specific medical care services and items as preventive care when prescribed to treat an individual diagnosed with certain chronic conditions. This delineation enables certain individuals to use Health Savings Account funds to pay for these items before the plan deductible is satisfied, which stands to lower costs for 60% of U.S. adults who have a chronic condition.

Remove Administrative Burdens Under Section 1557

Following notice and comment, regulations were revised to remove unnecessary tagline requirements, which is projected to save consumers $3.6 billion over a 5-year period.

Expand Use of Health Reimbursement Accounts

Regulations expanded the ability of employers to put aside money on a tax-free basis to help employees purchase health insurance, which provided employees with greater flexibility and choice in selecting their health care coverage.

Recent Activity

Above the FoldJul 22, 2021 - 5:15pm
 Arkansas Secretary of Health Dr. Jose Romero sits down with U.S. Chamber President and CEO Suzanne Clark. 

The Path Forward: Unvaccinated Far More Likely to be Hospitalized as Delta Variant Spreads

This week’s Path Forward event featured a discussion about the safety of COVID vaccines and the spread of the Delta variant.

EventJul 22, 2021 - 1:00pm to 1:45pm
Path Forward - Navigating the Return to Work Series Event Image

Path Forward: Why Americans Aren't Getting Vaccinated & What the Delta Variant Means for Your Business

Path Forward, a series produced by the U.S. Chamber Foundation, is designed to help business and community leaders find the answers they need to execute a responsible reopening strategy and plan for a post-pandemic world.

Letters to CongressJul 14, 2021 - 10:30am

U.S. Chamber Letter on FY22 Labor and HHS Appropriations

This Hill letter was sent to the Members of the House Committee on Appropriations, on the Fiscal Year 2022 Labor, Health and Human Services, Education, and Related Agencies Appropriations legislation.

Above the FoldJun 25, 2021 - 9:45am
U.S. Chamber President & CEO Suzanne Clark sits down virtually with WHO's Dr. Michael Ryan

The Path Forward: WHO Expert Says Pandemic Is Not Over

This week’s Path Forward event featured Dr. Mike Ryan, executive director of the WHO, on why the pandemic is not over.

Letters to CongressMay 04, 2021 - 1:45pm

U.S. Chamber Letter on H.R. 3, "Lower Drug Costs Now Act"

This Hill letter was sent to the Members of the U.S. House of Representatives, opposing H.R. 3, the "Lower Drug Costs Now Act." This bill is on the Legislative Leadership list for the “How They Voted” scorecard.

Above the FoldApr 30, 2021 - 11:00am
Path forward week of April 26

The Path Forward: Coronavirus Surge in India and School Reopening Successes in the US

This event focused on the American business community’s response to the devastating surge of coronavirus in India and school reopenings.

Above the FoldApr 29, 2021 - 12:30pm
U.S.-Israel

Expanding U.S.-Israel Partnerships in Health Innovation

Learn more about the U.S.-Israel Business Council's bilateral health innovation dialogue.

Press ReleaseApr 23, 2021 - 6:30pm

U.S. Chamber Calls on Administration to Distribute Vaccines to International Partners

WASHINGTON, D.C. – Myron Brilliant, Executive Vice President and Head of International Affairs at the U.S. Chamber of Commerce, issued the following statement calling on the administration to distribute U.S. vaccine supplies to international partners.

Press ReleaseApr 22, 2021 - 2:30pm

U.S. Chamber Opposes Government Price Controls That Will Destroy Jobs and Threaten Access

WASHINGTON, D.C. - The U.S. Chamber of Commerce strongly opposes H.R. 3, the “Lower Drug Costs Now Act of 2019,” which imposes government set price controls on prescription drugs. Members of Congress that refrain from cosponsoring this misguided legislation will receive credit for the Leadership component of the Chamber's “How They Voted” legislative scorecard.